Switch to
View more

Balaxi Pharmaceuticals Ltd

BALAXI
Health CareHealth Care Equipment & Supplies
SmallcapWith a market cap of ₹438 cr, stock is ranked 1,330
Moderate RiskStock is 2.95x as volatile as Nifty
438.3012.30 (+2.89%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CareHealth Care Equipment & Supplies
SmallcapWith a market cap of ₹438 cr, stock is ranked 1,330
Moderate RiskStock is 2.95x as volatile as Nifty

Key MetricsEdit

PE RatioPE Ratio
9.20
PB RatioPB Ratio
3.87
Dividend YieldDiv. Yield
0.11%
Sector PESector PE
38.16
Sector PBSector PB
4.82
Sector Div YldSctr Div Yld
0.92%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

The company is engaged in wholesale trading of pharmaceuticals products, food products and builders’ hardware products. The Company offers a range of food and biscuit products under the brand name YAP.

Investor PresentationView older 

Aug 2, 2022

PDF
View Older Presentations

Financial TrendFinancial statements 

201920202021202214.4946.22233.56284.361.986.0938.1347.66
Revenue
Profit
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

Schedule of Analysts/Institutional Investor Meet/Con. Call 
Announced OnAug 9, 2022

BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about Schedule of Analysts/Institutional Investor Meet/Con. Call | Download

BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about Schedule of Analysts/Institutional Investor Meet/Con. Call | Download

Schedule of Analysts/Institutional Investor Meet/Con. Call 
Announced OnAug 4, 2022

BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about Schedule of Analysts/Institutional Investor Meet/Con. Call | Download

BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about Schedule of Analysts/Institutional Investor Meet/Con. Call | Download

Cash Dividend 
Ex. DateJul 1, 2022

Final • Div/Share: ₹ 0.5

See all events